Ratings JTEC Corporation

Equities

3446

JP3386660009

Market Closed - Japan Exchange Other stock markets 11:30:00 15/05/2024 am IST			5-day change	1st Jan Change
1,760 ^JPY	-14.48%		-15.43%	-7.12%

2023	JTEC Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Ending June 30, 2024	CI
2023	Jtec Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Ending June 30, 2024	CI

Strengths

Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
The company's profit outlook over the next few years is a strong asset.
The group's high margin levels account for strong profits.

Weaknesses

The company benefits from high valuations in earnings multiples.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
JTEC CORPORATION	-7.12%	7.73Cr	-	-
ABBOTT LABORATORIES	-5.09%	18TCr		C+
MEDTRONIC PLC	+2.32%	11TCr		C
BECTON, DICKINSON AND COMPANY	-2.65%	6.79TCr		A
DEXCOM, INC.	+4.54%	5.01TCr		B-
CENCORA, INC.	+8.12%	4.43TCr		B-
HOYA CORPORATION	+9.39%	4.04TCr		B+
METTLER-TOLEDO INTERNATIONAL, INC.	+24.63%	3.2TCr		B
WEST PHARMACEUTICAL SERVICES, INC.	-0.03%	2.58TCr		A-
TERUMO CORPORATION	+17.27%	2.53TCr		A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes